Cancer immunotherapy is entering a new era of momentum.
From emerging modalities and clinical breakthroughs to the expanding real-world impact for patients, the field continues to reshape what’s possible in cancer care.
The 2026 CRI Cancer Immunotherapy Insights + Impact Report offers a comprehensive look at the science, innovation, and progress driving the future of immuno-oncology.
We’re proud to partner with the Cancer Research Institute to help amplify these advances and the global effort behind them.
Read the report here.